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Summary 
articular sodium hyaluronic acid (HA) has been used as a treatment intervention in the management of 
~eoar thr i t i s .  It has been observed that HA can coat the articular surface, and thus, has been suggested to provide 
a possib!e prophylactic barrier for the articular cartilage. In an accompanying manuscript (Homandberg et al.), 
~e report that a commercially available high-molecular-weight HA (approximately 800-kDa, ARTZ, Seikagaku Corp.) 
canpartial ly block fibronectin fragment (Fn-f)-mediated cartilage injury in vitro. Herein we report a study of the effects 
Of intra-articular HA on an in vivo animal model of Fn-f-mediated cartilage injury. Rabbit knees were injected with 
Fn-f, and after I week, the cartilage proteoglycan (PG) content had decreased to 59 _+ 8% of control. In sharp contrast, 
PG content in knees receiving pre-treatment with HA followed by Fn-f injection had only decreased to 85 _+ 27% of 
control (P < 0.01). Similarly, the PG content in knees receiving an injection of Fn-f, followed by an injection of HA 
were significantly higher (74 ± 18% of control) than Fn-f injured knees with no treatment (P < 0.02). Intra-articular 
HA alone had no effect on cartilage PG content. The results in this study suggest hat HA is effective in partially 
preventing Fn-f mediated cartilage injury, most likely by coating the articular surface. Further, HA treatment after 
Fn-f injury may facilitate restoration of matrix components. 
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Introduction 
IN order to study the progress ion of a r t i cu la r  
cart i lage injury, we have  developed an an imal  
model in which f ibronect in f ractment  (Fn-f) are 
used to in it iate severe cart i lage proteog lycan (PG) 
degradat ion  and depletion. The re levance of this 
model to human disease i s  supported by several  
points. First, Fn-f have  been identif ied in the 
synovia l  fluid of pat ients  with rheumato id  arthr i t i s  
[1, 2] and osteoarthr i t i s  (OA) [3, 4]. Second, 
Homandberg  et al. [5] reported that  ad jus tment  
of serum-free xp lant  cu l tures of bovine ar t i cu lar  
cart i lage to concentrat ions  of Fn-f found in 
diseased synovia l  fluid causes a 50% deplet ion of 
PG with in 3 days and cont r ibutes  to cart i lage 
damage by also depressing rates  of PG synthesis.  
Submitted 21 june 1996; accepted 16 December 1996. 
This work was supported inpart by grant 2-P50-AR39239 from 
the National Institutes of Health, The Arthritis Foundation, 
Greater Chicago Chapter, The Rice Foundation and Seikagaku 
Corporation (Tokyo, Japan). 
Address correspondence to: James M. Williams, Ph.D., 
Department ofAnatomy, Rush Medical College, 600 S. Paulina 
St., Chicago, I1 60612-3864, U.S.A. 
Third, we have recent ly  reported that  Fn-f- 
mediated cart i lage damage can be induced in vivo 
in adolescent  rabb i ts  in which in ject ion of Fn-f 
into rabb i t  knee jo ints  was shown to cause up to 
a 50% loss of cart i lage PG with in 7 days [6, 7]. 
Last ly,  the cont inu ing  character i zat ion  of the in 
vitro damage model  on which this in vivo model  is 
based has recent ly  shown that  the Fn-f may cause 
damage par t ly  or whol ly  th rough enhanced re lease 
of catabol ic  cytok ines [8]. Because these factors 
are thought  to be responsib le  for induct ion of the 
cart i lage sel f -destruct ion caused by the chondro-  
cytes in arthr i t is ,  especial ly  in OA, the i r  involve- 
ment  in the Fn-f model  enhances the s imi lar i t ies 
between this an imal  model and arthr i t is .  These 
observat ions  col lect ively suggest  that  the Fn-f 
damage model  may be very useful and re levant  for 
test ing biologic mater ia ls  which have a putat ive  
effect on cart i lage metabol ism. 
One of the" biologic mater ia ls  that  has received 
a great  deal of interest  as a potent ia l  agent  
of in tervent ion  in ar thr i t i s  is hya luron ic  acid 
(HA). HA is a nonsul fated,  h igh-molecular-weight ,  
unbranched po lysacchar ide  composed of repeat ing  
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disaccharide units of glucuronate l inked to 
N-acetyl glucosamine. It forms the backbone to 
which carti lage PG is attached via an HA binding 
region [9]. HA and'associated PG thus form a 
macromolecular aggregate. HA is also a major 
component of synovial fluid [10] and plays a central 
role in the joint cavity formation [11]. High- 
molecular-weight HA has been used in the 
treatment of human [12-18] and animal OA [19-22]. 
Intra-articular HA has been shown to reduce 
arthrit ic lesions in experimental models of canine 
[23, 24] and rabbit OA [25, 26]. An ameliorative 
effect of HA has also been demonstrated in 
a papain-induced model of art icular carti lage 
injury in guinea-pigs [27] and rabbits [2~8]. Intra- 
articular injections of HA effectively coat the 
articular surface of otherwise normal, intact 
articular carti lage [29]. In contrast, treatment with 
HA of carti lage where the surface has been 
disrupted, results in deeper penetration of HA 
into the crevices formed by the surface fibril lation 
and deeper penetration into the carti lage 
matrix. The biologic significance of this obser- 
vation is not known. However, the observation 
that the HA can cover the art icular surface 
suggests its possible use as a prophylactic barr ier 
against agents (e.g. cytokines) which induce 
matrix degradation. 
We have shown with in vitro studies that 
pre-incubation with HA reduced entry of Fn-f 
into tissue and led to blocking of Fn-f-induced 
PG loss (Homandberg et al., see Part I, precedomg 
manuscript). Additionally, HA reduced Fn-f-medi- 
ated stromelysin expression and suppressidn of 
PG synthesis. The purpose of the present study 
was to determine whether intra-art icular HA 
could provide a protective barrier against matrix 
damage and facil itate restoration Of lost matrix 
components which occurs in vivo following the 
intra-articular injection of Fn-f. 
Exper imenta l  Des ign  and Methods  
ANIMALS AND EXPERIMENTAL GROUPS 
Adolescent, skeletally-immature male New 
Zealand White rabbits (3.0-3.5 kg) were housed 
individually in cages provided in the Comparative 
Research Center at The Rush Presbyterian St. 
Luke's Medical Center. Animals were fed Pur ina 
Rabbit Chow, and their food intake was monitored 
daily. Ninety animals ~ere randomly assigned to 
nine groups (N= 10 animals/group). Five untreated 
control animals were killed with the animals in 
four experimental groups after 1 week (Table I; 
short:term). In order to study these effects over a 
longer period of time, animd~ts in four additional 
experimental groups and five untreated controls 
were killed after 4 weeks (Table I; long-term). 
The positive control group (Fn-f injury) received 
an intra-articular injection of Fn-f (3 pM 29/50-kDa 
in 0.3 ml saline) into the left knee with no further 
Table I 
Experimental design 
(a) Short-term animals 
Group N Day -1 Day 0 Day 1 Day 7 
Fn-f injury 10 Fn-f* Sacrifice 
Pre-Fn-f injury HA 10 HAt Fn-f* Sacrifice 
Post-Fn-f injury HA 10 Fn-f* HAt Sacrifice 
HA control 10 HAt Sacrifice 
Untreated control 5 Sacrifice 
(b) Long-term animals 
Group N Day -1 Day 0 Day 1 Week 4 
Fn-f injury 10 Fmf* Sacrifice 
Pre-Fn-f injury HA 10 HAt Fn-f* Sacrifice 
Post~Fn-f injury HA 10 Fn-f* HAt Sacrifice 
HA control 10 HAt Sacrifice 
Untreated control 5 Sacrifice 
*0.3 ml of a 3 mM 29/50-kDa Fmf saline. 
t0.3 ml of a 10 mg/ml HA (about 800-kDa) solution in saline. 
Allocation of animals into experimental and control groups for both short- (1 week) and 
long-term (4 weeks) animals. HAt indicates the timing of the HA injection and Fn-f* 
indicates the timing of Fn-f injection. 
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treatment (Tables I and II). In order to test 
the ability of HA (approximately 800-kDa, ARTZ, 
Seikagaku Corp.: referred to as HA/800 in the 
~:feeeding manuscript) to coat the articular surface 
~d:  ~educe Fn-f-induced amage, another group of 
~!s (Pre-HA) received an mtra-artlcular 
}njec~ion of HA (0.3 ml of a 10 mg/ml solution) into 
th~ left knee 1 day before they received an 
~nt~a~articular injection of 29/50-kDa Fn-f (3 gM in 
~ )  into the same knee. In order to test the 
~I : i ty  of intra-articular HA to restore lost matrix 
~:Onents ,  another group of rabbits (Post-HA) 
~ i :V~d an intra-articular injection of 29/50-kDa 
I(3~M in 0.3 ml) into the left knee and 1 day 
~::iii ~ :  intra-articular injection of HA (0.3ml 
~iii:~:i,:i~mg]ml solution) into the same knee. A 
c~ht~l  group of rabbits (HA only) received 
a~ }ntra-articular injection of HA (0.3 ml of a 
tOmg/ml solution) into the left knee with no 
further treatment. 
ISOLATION OF RABBIT Fn-f 
Rabbit plasma was purchased from Pell-Freeze 
and Fn purified by adsorption to gelatin-Sepharose 
as modified [30] and Fn-f isolated. Fn-f from rabbit 
plasma Fn were generated from sequential cathep- 
sin D and thrombin digests and a mixture of the 
two most potent Fn-f, the 29-kDa and 50-kDa Fn-f, 
were tested. This mixture (approximately 1 : 1 molar 
ratio) is denoted as 29/50-kDa Fn-f. Immediately 
before injection, the 29/50-kDa Fn-f solutions were 
dialyzed against 50 mM phosphate, 100 mM NaC1, 
pH 7.0, without protease inhibitors and sterile- 
filtered. Periodic testing for endotoxin with the 
endotoxin kit from Sigma Chemical Co. typically 
has shown insignificant levels of less than 50 pg/ml 
protein. 
IN JECT ION PROCEDURE 
Animals were anesthetized by an intra-muscular 
injection of a mixture of ketamine (80 mg/cm 3) and 
acepromazine (210mg/cm 3) at a dose of 1.0 cm3/ 
1.5 kg body weight after which the. left knee was 
washed with 70% isopropyl alcohol. The injection 
was performed under aseptic conditions by passing 
a 26-gauge needle attached to a tuberculin syringe 
through the joint capsule lateral to the patellar 
tendon. Injected joints were moved through a few 
extension/flexion movements to ensure equal 
distribution of the injected materials throughout 
the joint cavity. Animals were then placed in their 
pens and permitted to recover from the anesthetic. 
All animals tolerated the injection procedure well 
with no adverse reactions. 
ANALYTICAL PROCEDURES 
Both knees were opened immediately after death 
and examined grossly. Full-thickness havings of 
articular cartilage from the central, habitual ly 
loaded region of the medial femoral condyle and 
medial tibial plateau were obtained for determi- 
nation of PG content. Cartilage samples were 
weighed and then digested in 1.0ml of 50raM 
phosphate buffer, pH 6.0, containing 10 mM EDTA, 
10 mM cysteine and 27 l~g/ml papain for 8 h at 60°C. 
The digests were then subjected to the dimethyl- 
methylene blue (DMB) assay as described in 
modified form [5, 7]. Thus, cartilage PG content 
wag expressed as gg PG/mg cartilage wet weight. 
Data from control and experimental samples were 
then examined by analysis of variance (ANOVA) 
with paired tests to determine the nature of the 
relationships among the experimental groups. For 
histology samples of the patellae, including the 
parapatellar synovium, were fixed for 1 week in 
10% neutral buffered formalin containing 5% cetyl 
pyridinium chloride, decalcified in formic 
acid:sodium citrate (44% formic acid:20% sodium 
citrate) for 2 weeks and embedded in paraffin. 
Microscopic sections (8 pm) of the samples were 
stained with Toluidine blue or Safranin=0 to 
demonstrate matrix PG and counterstained with 
fast g reen  [31] or with hematoxylin and eosin. 
Sections from the left (injected) knees and the 
untreated control right knees of each experimental 
animal were stained concurrently to control for 
variations in uptake of the stain. 
Resu l ts  
SHORT-TERM GROUPS 
Short-term groups, killed after 1 week, showed 
a significant beneficial effect of HA in terms of 
cartilage PG content when HA was injected before 
or after the Fn-f. In controls, cartilage PG contents 
were within normal limits (range 20-37 pg PG/mg 
cartilage) for the untreated control animals which 
served as a baseline for statistical comparisons. 
Wh~h expressed as a per cent of control for the 
purposes of comparisons (Fig. 1), values were 
109 + 16% of control (left knee divided by the right 
knee×100 _+ S.D.). Cartilage PG contents for ani- 
mals receiving HA only into the left knee were 
102_+ 32% of control (range 25-37~g PG/mg 
cartilage). 
However, for the experiment groups, the carti- 
lage PG content was markedly reduced to 59 ± 8% 
of control in animals which received~ Fn-f injury 
with no HA treatment (range 13-26 ~g PG/mg 
cartilage). This was significantly different than 
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FIa. 1. Cartilage PG content expressed as a per cent of the (right) contralateral control knee. The horizontal line 
indicates the 100% or normal expected levePof cartilage PG content. The closed (black) boxes indicate short-term 
animals; open (white) boxes indicate long-term animals; closed (black) box on right indicates normal, untreated 
animals. 
the untreated control animals (P < 0.0001). Pre- 
treatment of the joint with an injection of HA 
followed 1 day later by the Fn-f injury resulted in 
higher cartilage PG contents (85 + 27% of control; 
P< 0.01) after 1 week (range 15-32~g PG/mg 
cartilage). Cartilage PG contents for animals 
which were pretreated with HA before Fn-f injury 
were not significantly different from animals 
which received HA only or from untreated control 
animals. In contrast, Fn-f injury followed 1 day 
later by HA treatment resulted in higher cartilage 
PG contents of 74 ± 18% of control (P < 0.02) when 
compared to Fn-f injury with no treatment (range 
17-31 pg PG/mg cartilage). 
Morphology 
Short-term groups, killed after 1 week, showed a 
significant beneficial effect of HA also in terms of 
morphology when HA was injected before or after 
the Fn-f. The joints were slightly swollen as a 
result of the Fn-f injection procedure. However, 
the swelling was reduced generally after 3-4 days 
so that at the time of death minimal joint swelling 
was noted. Upon gross examination, the articular 
cartilage from animals killed 1 week after Fn-f 
injection with no further treatment, was dull and 
pale. In contrast, cartilage was glistening white in 
all untreated control knees, Fn-f injected knees 
treated with HA, knees injected with HA only, and 
in all knees from animals in the long-term groups 
killed after 4 weeks. 
In terms of this histology/histochemistry of 
the short-term groups, in all control knees, the 
articular surface, joint margin (site of osteo- 
phyte formation), cell density, clone formation, 
Safranin-O and Toluidine Blue staining and 
parapatellar synovial membrane were normal. The 
articular surface, joir~t margin, cell density, clone 
formation and parapatellar synovial membrane 
were normal 1 week after intra-articular injec- 
tion of the 29/50-kDa Fn:f with and without HA 
treatment. The most striking change resulting 
from Fn-f injury was the loss of Safranin-O and 
Toluidine Blue staining indicating loss of matrix 
PG. Reduced Safranin-O ~nd Toluidine Blue 
staining was also noted in animals receiving HA 
before and after Fn-f injury. As expected, HA 
injection alone had no significant effect on 
Safranin-O or Toluidine Blue staining. 
LONG-TERM GROUPS 
Long-term groups, killed four weeks after 
injection of Fn-f, showed spontaneous reversal of 
morphologic changes and PG content changes 
whether or not HA was also injected. Four weeks 
after Fn-f injury, the only damage which remained 
consisted of a slight to moderate reduction in 
Safranin-O and Toluidine Blue staining of the 
articular cartilage. Thus, the articular surface, 
joint margin, cell content and parapatellar 
synovial membrane were normal. No clone for- 
mation was noted. A similar picture was seen in all 
joints injected with Fn-f and treated with HA. 
Importantly, HA injection alone resulted in 
normal Safranin-O and Toluidine Blue staining 
after 4 weeks. 
In terms of PG content, after 4 weeks, cartilage 
PG content had returned to normal values of 
100 + 24% of control in animals which received 
Fn-f injury with no HA treatment (range 34-53 ~g 
PG/mg cartilage) (Fig. 1). Pretreatment with HA, 
followed by Fn-f injury, resulted in PG contents of 
103 _ 41% of control after 4 weeks. Cartilage PG 
contents were generally lower in animals that 
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~eeeived HA 1 day after Fn-f injury (81 + 31% of 
~6~trol), but these levels were not significantly 
different from untreated control animals. After 
~i!i, lw~eks, HA treatment alone caused no loss 
~o!~ cartilage PG loss so that PG values were 
of control. Therefore, the Fn-f treated 
i~ i~:cent  rabbits spontaneous recovered their i! i ;  
!~ ~Gs after 4 weeks with or without injected 
Discuss ion 
~!~ a naturally-occurring component of 
~ l  ~uid [32]. It functions, in part, to provide 
~ i o n  for moving joint structures and coats 
fiIar surface. In addition, it has been 
theorized that HA may also function to coat the 
~ c ~  surface and provide a protective barrier 
~:~t  various cytokines [33, 34]. The most 
s~f icant  result of this study was that intra- 
~t~c~lar HA was effective in partially preventing 
F~f :mediated cartilage injury. If animals were 
~ ~reated with a single injection of HA followed 
1day  later by Fn-f injury, cartilage PG contents 
were significantly higher. Thus, HA provided a 
prophylactic effect against Fn-f-induced articular 
cartilage injury. 
The mechanism by which HA may block the Fn-f 
mediated injury is likely by blocking entry of the 
Fn-f into cartilage tissue. We have shown that 
a portion of the 29-kDa Fn-f added to cultured 
cartilage in vitro concentrates on the articular 
cartilage surface in a mode which is reversible and 
ionic in nature, and may thus, involve interaction 
with PG [35]. A small fraction transfers to the 
internal matrix, and eventually binds to cell 
clusters half-w~/y through the full thickness 
of the cartilage sections [35]. Therefore, it is 
likely that cartilage surface-coating a ents would 
limit the transfer of the Fn-f into the cartilage 
matrix. Indeed, we have shown in the preceding 
manuscript (Homandberg et al.), that HA coats 
the articular surface, suppresses most of the 
accumulation of Fn-f on the articular surface, 
decreases the diffusion of the Fn-f into the tissue 
matrix, and decreases the density of the Fn-f 
which surround the cells. 
The results in the present study also demon- 
strated that intra-articular HA which is adminis- 
tered one day after Fn-f injury may also retard 
Fn-f-mediated chondrocytic chondrolysis cartilage 
over the short-term in adolescent rabbits. If 
animals were treated with HA 1 day after Fn-f 
injury, cartilage PG contents were significantly 
higher than in joints w-ith no I-IA treatment. Th~s, 
HA appeared to facilitate the restoration of lost 
matrix PG which follows Fn-f-induced carti lage 
injury. Importantly, intra-articular HA alone did 
not alter cartilage PG content in otherwise normal 
joints or in joints such as in the long-term groups 
which were undergoing spontaneous repair. 
The enhanced restoration of PGs lost by Fn-f 
injection as observed here in vivo is difficult 
to explain, although a similar observation of 
repair in the presence of HA was also observed 
in the in vitro Fn-f damage model as discussed 
in the preceding manuscript (Homandberg et al.). 
Other work has shown that Fn-f injury 
is associated with elevated levels of metallo- 
proteinase and catabolic cytokines [5, 6, 36]. 
Perhaps coating the surface with HA and slowing 
the effusion of metalloproteinases and cyto- 
kines from damaged cartilage or preventing their 
re-entry into the tissue [37] would slow degradative 
processes which may continue in cartilage allowed 
to repair. Alternatively, the injected HA, without 
necessarily binding to the surface, may also bind to 
soluble mediators uch as cytokines or metallo- 
proteinases, which may still be present at elevated 
levels in tissue allowed to repair, and block 
their effectiveness. Another possibility, as dis- 
cussed in the preceding manuscript (Homandberg 
et al., is that HA acts as an anti-oxidant 
and blocks cytokine activation which has been 
shown to remain elevated in cartilage allowed to 
repair. 
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